Old Web
English
Sign In
Acemap
>
authorDetail
>
Fangniu Shi
Fangniu Shi
Chemistry
Physical therapy
Antibody
Regimen
Randomized controlled trial
3
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 3, open-label, multicenter, randomized study to investigate the efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus docetaxel in patients with non-small cell lung cancer who have progressed on a prior platinum-containing regimen.
2018
Journal of Clinical Oncology
Dingzhi Huang
Ziping Wang
Xinmin Yu
Ying Cheng
Jie Wang
Yun Fan
Zhiyong Ma
Jianhua Shi
Yan Yu
Yi Hu
James Song
Fan Xia
Zhirong Shen
Yun Zhang
Yingying Xu
Carrie Condon
Fangniu Shi
Yunfei Zhou
Andrea Pirzkall
Caicun Zhou
Show All
Source
Cite
Save
Citations (0)
Concise Synthesis and Antimicrobial Activities of New Substituted 5-Isoxazolpenicillins
2007
Journal of The Chinese Chemical Society
Xi-Zhao Wang
Jiong Jia
Yan Zhang
Wei-Ren Xu
Wei Liu
Fangniu Shi
Jian-Wu Wang
Show All
Source
Cite
Save
Citations (5)
The theoretical investigation of the binding mode between human serum albumin and penicillins
2006
Nan Wu
Fangniu Shi
Wei Liu
Wei-Ren Xu
Show All
Source
Cite
Save
Citations (0)
1